MedPath

Evaluation of the concurrent polyethylene glycol and probiotic in treatment of constipatio

Phase 2
Conditions
Constipation.
Constipation
K59.0
Registration Number
IRCT20171030037093N12
Lead Sponsor
Vice chancellor for research, Shahrekord University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
150
Inclusion Criteria

Suffering from chronic functional constipation
Age from 2 to 15 years
Not being infected with large and small intestinal diseases
Insomnia to polyethylene glycol
Lack of bowel obstruction
The absence of kidney or heart failure

Exclusion Criteria

Creating diarrhea following a drug
Create unwanted allergic reactions after taking medication

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
nwanted exclusion. Timepoint: Before and during the first and second weeks after treatment. Method of measurement: Check list.;Excretion of stool. Timepoint: Before and during the first and second weeks after treatment. Method of measurement: Check list.;Painful exclusion. Timepoint: Before and during the first and second weeks after treatment. Method of measurement: Check list.;Stomach ache. Timepoint: Before and during the first and second weeks after treatment. Method of measurement: Check list.;Consistency. Timepoint: Before and during the first and second weeks after treatment. Method of measurement: Check list.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath